Abstract
Clinical trials have demonstrated new, safe, efficacious ways to use these cardiovascular agents: Beta-blockers are now first-line treatment for heart failure, and the HOPE trial showed that ACE inhibitors reduce morbidity and mortality in patients at high risk of cardiac events.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 62-84 |
| Number of pages | 23 |
| Journal | Patient Care |
| Volume | 34 |
| Issue number | 13 |
| State | Published - 2000 |
ASJC Scopus subject areas
- Leadership and Management
Fingerprint Dive into the research topics of 'Beta-blockers and ACE inhibitors: New data, old myths'. Together they form a unique fingerprint.
Cite this
Francis, G. S., Lewis, W. R., Parmley, W., & Weart, C. W. (2000). Beta-blockers and ACE inhibitors: New data, old myths. Patient Care, 34(13), 62-84.